200 related articles for article (PubMed ID: 25998232)
1. Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways.
Han YS; Lee JH; Lee SH
Mol Med Rep; 2015 Sep; 12(3):3446-3452. PubMed ID: 25998232
[TBL] [Abstract][Full Text] [Related]
2. Fucoidan from seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways.
Lee H; Kim JS; Kim E
PLoS One; 2012; 7(11):e50624. PubMed ID: 23226337
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
Kim IH; Nam TJ
Oncol Rep; 2018 Mar; 39(3):1516-1522. PubMed ID: 29328495
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Effect of Fucoidan on DU-145 Prostate Cancer Cells through Inhibition of PI3K/Akt and MAPK Pathway Expression.
Choo GS; Lee HN; Shin SA; Kim HJ; Jung JY
Mar Drugs; 2016 Jul; 14(7):. PubMed ID: 27399727
[TBL] [Abstract][Full Text] [Related]
5. Caspase-dependent and caspase-independent induction of apoptosis in breast cancer by fucoidan via the PI3K/AKT/GSK3β pathway in vivo and in vitro.
Xue M; Ji X; Xue C; Liang H; Ge Y; He X; Zhang L; Bian K; Zhang L
Biomed Pharmacother; 2017 Oct; 94():898-908. PubMed ID: 28810530
[TBL] [Abstract][Full Text] [Related]
6. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.
Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S
Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926
[TBL] [Abstract][Full Text] [Related]
7. Differences in cell death and cell cycle following fucoidan treatment in high-density HT-29 colon cancer cells.
Kim IH; Kwon MJ; Nam TJ
Mol Med Rep; 2017 Jun; 15(6):4116-4122. PubMed ID: 28487956
[TBL] [Abstract][Full Text] [Related]
8. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
9. Fucoidan Induces ROS-Dependent Apoptosis in 5637 Human Bladder Cancer Cells by Downregulating Telomerase Activity via Inactivation of the PI3K/Akt Signaling Pathway.
Han MH; Lee DS; Jeong JW; Hong SH; Choi IW; Cha HJ; Kim S; Kim HS; Park C; Kim GY; Moon SK; Kim WJ; Hyun Choi Y
Drug Dev Res; 2017 Feb; 78(1):37-48. PubMed ID: 27654302
[TBL] [Abstract][Full Text] [Related]
10. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
11. Silencing Prion Protein in HT29 Human Colorectal Cancer Cells Enhances Anticancer Response to Fucoidan.
Yun CW; Yun S; Lee JH; Han YS; Yoon YM; An D; Lee SH
Anticancer Res; 2016 Sep; 36(9):4449-58. PubMed ID: 27630281
[TBL] [Abstract][Full Text] [Related]
12. Isorhamnetin suppresses colon cancer cell growth through the PI3K‑Akt‑mTOR pathway.
Li C; Yang X; Chen C; Cai S; Hu J
Mol Med Rep; 2014 Mar; 9(3):935-40. PubMed ID: 24398569
[TBL] [Abstract][Full Text] [Related]
13. CXC195 induces apoptosis and endoplastic reticulum stress in human hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway.
Chen XL; Fu JP; Shi J; Wan P; Cao H; Tang ZM
Mol Med Rep; 2015 Dec; 12(6):8229-36. PubMed ID: 26496900
[TBL] [Abstract][Full Text] [Related]
14. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
15. The anticancer effect of fucoidan in PC-3 prostate cancer cells.
Boo HJ; Hong JY; Kim SC; Kang JI; Kim MK; Kim EJ; Hyun JW; Koh YS; Yoo ES; Kwon JM; Kang HK
Mar Drugs; 2013 Aug; 11(8):2982-99. PubMed ID: 23966032
[TBL] [Abstract][Full Text] [Related]
16. Anti-metastasis effect of fucoidan from Undaria pinnatifida sporophylls in mouse hepatocarcinoma Hca-F cells.
Wang P; Liu Z; Liu X; Teng H; Zhang C; Hou L; Zou X
PLoS One; 2014; 9(8):e106071. PubMed ID: 25162296
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin induces colon cancer cell proliferation through the GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways.
Lien GS; Lin CH; Yang YL; Wu MS; Chen BC
Eur J Pharmacol; 2016 Apr; 776():124-31. PubMed ID: 26879868
[TBL] [Abstract][Full Text] [Related]
18. AKT signaling is involved in fucoidan-induced inhibition of growth and migration of human bladder cancer cells.
Cho TM; Kim WJ; Moon SK
Food Chem Toxicol; 2014 Feb; 64():344-52. PubMed ID: 24333868
[TBL] [Abstract][Full Text] [Related]
19. NSK-01105 inhibits proliferation and induces apoptosis of prostate cancer cells by blocking the Raf/MEK/ERK and PI3K/Akt/mTOR signal pathways.
Yu P; Ye L; Wang H; Du G; Zhang J; Zhang J; Tian J
Tumour Biol; 2015 Mar; 36(3):2143-53. PubMed ID: 25398692
[TBL] [Abstract][Full Text] [Related]
20. Fucoidan inhibits proliferation of the SKM-1 acute myeloid leukaemia cell line via the activation of apoptotic pathways and production of reactive oxygen species.
Wei C; Xiao Q; Kuang X; Zhang T; Yang Z; Wang L
Mol Med Rep; 2015 Nov; 12(5):6649-55. PubMed ID: 26324225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
